Conference Coverage
Conference Coverage
In metastatic breast cancer, primary resections on the decline
The trend follows randomized, controlled trials that showed no survival benefit to surgery.
News
IUDs may increase background enhancement on breast MRI
However, “the study findings raise the question as to whether IUD status should be documented as a matter of course prior to performing breast MRI...
Conference Coverage
What’s hot at the world’s premiere breast cancer meeting
An important study of an investigational oral agent for postmenopausal women who have been treated for ER positive advanced breast cancer...
News
Exercise reduces arm and shoulder problems after breast cancer surgery
Study provides the best quality evidence to date in support of early exercise for women at high risk of shoulder problems after breast cancer...
News
Success in closing racial survival gap in lung and breast cancer
Adopting internal changes to system processes can eliminate racial disparities in cancer survival while improving survival for for all patients....
News
NCI mammography trial mostly a ‘waste,’ says expert
Harvard physician says TMIST is underpowered and as a result, may be misleading.
Conference Coverage
Many patients, doctors unaware of advancements in cancer care
“These patients must be spared the traumatic effects of being handed a death sentence that no longer reflects the current reality,” said Dr....
News
Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancer
Trastuzumab duocarmazine is a novel HER2-targeting antibody-drug conjugate which, according to the results of the TULIP trial recently presented...
Conference Coverage
Treatment shows 'important improvements' in triple-negative breast cancer
Survival of patients without an initial diagnosis of triple-negative breast cancer was better with the antibody-drug conjugate, compared with...
Conference Coverage
TULIP trial shows extended survival in HER2+ metastatic breast cancer
Progression-free survival was up to 7 months in some cases, but with adverse events.